RNA Outsourcing Solutions
-
Biologics Manufacturing
5/15/2024
Recipharm Advanced Bio GMP manufacturing units focus on process robustness and consistency to ensure product quality, purity and efficacy. Our multi-product manufacturing facilities feature state-of-the-art equipment for animal cell-derived viral and microbial products for your clinical trials in phase 1-2 and in accordance with cGMP guidelines.
-
Plasmid DNA Manufacturing
1/31/2023
As a critical starting material in the production of many advanced therapies including viral vectors and RNA vaccines, cell and gene therapy research at any scale requires plasmid DNA manufacturing. Our specialists provide custom plasmid production that fits your project specifications. To save time and accelerate your cell and gene therapy programs, we also offer off-the-shelf, premanufactured, High Quality viral vector packaging plasmids.
-
Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles
Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.
-
Comprehensive Solutions For Your Vaccine Platforms
Vaccine production, from process development to full-scale GMP-manufacturing, must be efficient, safe, and cost-effective. Learn how our global capabilities can help you achieve these goals for all your modalities/platforms.
-
Measure Quality Attributes Faster mRNA And LNP Analytical Services
10/8/2024
Accelerate your drug discovery and development process by leveraging comprehensive quality insights for faster and more effective results.
-
NanoImprove The Performance Of Your Biologic Formulation
11/20/2025
Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.
-
Bridging The Gaps: Enhancing First And Last Mile Resilience
7/28/2025
Designed as a dedicated, short-range logistics service for the life sciences, Cryoshuttle reinforces chain of custody, ensures near real-time visibility, and preserves product integrity from start to finish.
-
Nanoplasmid Vector Platform
5/6/2026
Smaller vector backbones boost yield, expression, and transfection while lowering toxicity and regulatory risk, enabling efficient viral, non‑viral, and mRNA workflows from research to clinic.
-
Unlock The Power Of mRNA With Analytical Testing
4/16/2026
Ensure your mRNA therapeutics meet evolving regulatory expectations by leveraging advanced analytical testing for characterization, stability, and product release aligned with the latest USP standards.
-
Transforming Drug Delivery
3/1/2024
Learn how our team of scientists, engineers, and human-centered designers, as well as our world-class facilities, empower us to confidently guide your product toward a successful market launch.